For the Inventor, By the Inventor

Enter assignee name

Public University Corporation Nagoya City University

USPTO Granted Patents = 25

CIPO Patents = 1

EPO Patents = 13

Forward Citations = 17

Loading Chart...

Loading Chart...

95 inventors (with patents filed for the assignee):

Takahiro Iwao (5 out of 5 patents)

Tamihide Matsunaga (5 out of 5 patents)

Yasuhito Tanaka (4 out of 5 patents)

4. Shinji Sugiyama (3 out of 51 patents)

5. Kiyoko Yokoyama (3 out of 3 patents)

6. Issey Takahashi (3 out of 3 patents)

7. Takayoshi Ito (2 out of 27 patents)

8. Akimichi Morita (2 out of 4 patents)

9. Yutaka Kondo (2 out of 2 patents)

10. Keisuke Katsushima (2 out of 2 patents)

11. Masayoshi Toyoura (2 out of 5 patents)

12. Yuji Shoya (2 out of 5 patents)

13. Chihiro Yamazaki (2 out of 4 patents)

14. Junpei Yamanaka (2 out of 6 patents)

15. Akiko Toyotama (2 out of 4 patents)

25 patents: Sort by Forward Citations

1. 12448464 - Anti-PAD4 antibody (2025-10-21),

2. 12344864 - Artificially synthesized mRNA and use of same (2025-07-01),

3. 12134784 - Method for preparing intestinal tract cell layer derived from pluripotent stem cell (2024-11-05),

4. 12054746 - Method for inducing differentiation of pluripotent stem cells into intestinal epithelial cells (2024-08-06),

5. 11859212 - Method for producing intestinal organoid derived from pluripotent stem cells (2024-01-02),

6. 11828750 - Material for screening for compound acting on ION channel and use thereof (2023-11-28),

7. 11725189 - Maintenance culture of induced pluripotent stem cell-derived intestinal stem cells (2023-08-15),

8. 11499963 - Induction of differentiation of induced pluripotent stem cells into intestinal epithelial cells (2022-11-15),

9. 11447569 - Anti-PAD4 antibody (2022-09-20),

10. 11338153 - Phototherapeutic apparatus and protocol setting method for phototherapeutic apparatus (2022-05-24),

11. 11219598 - Ophthalmic drug sustained release device (2022-01-11),

12. 11066665 - Antitumor drug delivery formulation (2021-07-20),

13. 10907216 - Prediction of hepatocellular carcinoma onset after clearance of hepatitis C virus (2021-02-02),

14. 10675604 - Eutectic colloidal crystal, eutectic colloidal crystal solidified body, and methods for producing them (2020-06-09),

15. 10563201 - Method for treatment of subjects with TUG1 gene expressing brain tumor (2020-02-18),

Nagoya City University, operated by Public University Corporation Nagoya City University, is a leading educational institution in Nagoya, Japan. Offering a diverse range of undergraduate and graduate programs, the university aims to cultivate talented individuals, promote innovative research, and contribute to the local and global communities. With a focus on interdisciplinary studies and practical education, Nagoya City University prepares students for successful careers and societal contributions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

25 Patents

#37 in Nagoya

#2,517 in Japan

#24,910 in the World

Public University Corporation Nagoya City University

Forward Citations = 17

95 inventors:

Takahiro Iwao (5 out of 5 patents)

Tamihide Matsunaga (5 out of 5 patents)

Yasuhito Tanaka (4 out of 5 patents)

4. Shinji Sugiyama (3 out of 51 patents)

5. Kiyoko Yokoyama (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…